SynthesisThe journal of headache and pain2026
Migraine in pediatric population: the role of biochemical markers.
Synthesis in The journal of headache and pain, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Pharmacological Modulation of the Kynurenine Pathway Using PF-04859989 Modulates PACAP Signaling in Migraine-Relevant Trigeminal Sensitization.Biomolecules · 2026Article
- Clinical characteristics and exploratory serum biomarker findings in vestibular migraine: a cross-sectional case-control study.Frontiers in neurology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDiagnosis of migraine remains primarily clinical, and objective biological markers are lacking. Although biomarker research has expanded considerably in adults, evidence in pediatric populations remains fragmented and heterogeneous. This systematic review aimed to synthesize current data on biochemical markers in pediatric migraine and to evaluate their potential diagnostic, monitoring, prognostic, and treatment-response roles.
methodsThe review was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. PubMed, Embase and Scopus were searched up to January 1st, 2026. Studies investigating biochemical markers in individuals younger than 18 years diagnosed with episodic or chronic migraine according to International Classification of Headache Disorders 3rd edition (ICHD-3) criteria were included. Biomarkers assessed in blood, saliva, urine, cerebrospinal fluid, or stool were considered. Due to substantial heterogeneity in study design, sampling timing and laboratory methods, findings were synthesized narratively.
resultsTwenty-eight studies met inclusion criteria. Neuropeptides were the most extensively investigated biomarkers. Ictal elevation of calcitonin gene-related peptide (CGRP) was the most reproducible finding, supporting a disease-activity monitoring role, whereas interictal levels showed inconsistent results. Pituitary adenylate cyclase–activating polypeptide 38 (PACAP-38) and vasoactive intestinal peptide (VIP) demonstrated variable associations and may contribute within multimarker panels. Mitochondrial stress markers (growth differentiation factor-15, fibroblast growth factor-21 and hypoxia-inducible factor-1α) were elevated during attacks and in chronic migraine, suggesting links with metabolic stress and disease burden. MicroRNAs emerged as preliminary treatment-responsive candidates. Gut microbiota studies showed consistent β-diversity alterations and shifts in tryptophan metabolism; ratio-based kynurenine metabolites displayed promising diagnostic performance. Among inflammatory markers, tumor necrosis factor (TNF)-axis activation and interleukin (IL)-12p70 were the most reproducible signals.
conclusionsNo single biomarker currently supports standalone clinical application. Pathway-based multimarker approaches may improve biological stratification and monitoring in pediatric migraine. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.